OPK OPKO Health, Inc.: Market Capitalization to Book Value Ratio

Official company branding of OPKO Health Corp. (OPK)

The price action of OPKO Health, Inc. (OPK) reflects the market positioning of the diagnostic center operator. The business faces aggressive pressure from industry behemoths and the expansion of at-home rapid tests, with the key metric standing at 1.02. Stability is maintained by its reputation as a reliable provider of precise diagnostics. The structure gains additional resilience from its global pharmaceutical division, which offsets the volatility and low yields of the core laboratory segment.

OPKO Health Corp. (OPK): Capitalization to Book Value Ratio from 07/04/2022 to 10/28/2026
Core merchandise of OPKO Health Inc

To assess the credit quality of OPKO Health, Inc. (OPK), the analyst examines the market-to-book value trend, which determines the market premium for every dollar of net assets. A high level of this metric confirms investor confidence in the diagnostic accuracy of BioReference and the company's biopharmaceutical innovations, although a sharp increase in the indicator may signal an overvaluation of the business relative to its actual balance sheet.

Main competitors

A (Agilent Technologies) - Market Value to Book Value Ratio|questdiagnostics.com (DGX) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio ILMN (Illumina)|Market-to-Book Ratio Exact Sciences Corp|Market Capitalization to Book Value Ratio PerkinElmer RVTY|Capitalization to Book Value Ratio Bio-Rad Corp (BIO)|Market Capitalization to Book Value Ratio NNNN (Anbio Biotechnology)|soterahealth.com - Market Capitalization to Book Value Ratio|QuidelOrtho Corporation (QDEL) - Market Value to Book Value Ratio|CDNA - Capitalization to Book Value Ratio|MRVI: Market Capitalization to Book Value Ratio|FLGT (Fulgent) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Standard BioTools Inc.|Market Value to Book Value Ratio cytekbio.com (CTKB)|OraSure - Market Cap to Net Assets Ratio|Market-to-Book Ratio XGN (exagen.com)|Market Value to Book Value Ratio MDXH|Market Capitalization to Book Value Lucid Diagnostics, Inc LUCD|Market Capitalization to Book Value Ratio PRE (Prenetics Global Ltd)|IMDX: Market Capitalization to Book Value|trinitybiotech.com - Market Value to Book Value Ratio|PRPH (ProPhase Labs Inc) - Market Capitalization to Book Value|Market Value to Book Value Ratio AIMD (Ainos Corp)|Market-to-Book Ratio CODX|HSCS - Market Value to Book Value Ratio|Market Capitalization to Net Assets BMRA (biomerica.com)|Market Value to Book Value Ratio CDIO (Cardio Diagnostics Holdings)|Virax Biolabs Group Limited - Market Capitalization to Book Value Ratio|BJDX (Bluejay) - Market Value to Book Value Ratio|Aspira Women's Health Inc (AWH) - Market-to-Book Ratio|Market Cap to Net Assets Ratio Accelerate Diagnostics AXDX|CENTOGENE (CNTG) - Market Value to Book Value|ENZ - Market Capitalization to Book Value Ratio|Market Value to Book Value Fresh2|Genetic Technologies - Market Capitalization to Book Value Ratio|Market-to-Book Ratio 23andMe Inc (ME)|Market Capitalization to Book Value Ratio PMD (Psychemedics)